Home Healthcare Pharmaceuticals Pulmonary Arterial Hypertension Market

Pulmonary Arterial Hypertension Market Size, Share & Trends Analysis Report By Drug Class (Prostacyclin and Prostacyclin Analogs, SGC Stimulators, ERA, PDE-5) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Last Updated: June 03, 2026 | Author: Mitiksha Koul | Format:
Overview TOC Segmentation Methodology
Download Free Sample

Table Of Content

  1. Executive Summary
  2. Research Scope & Segmentation
    1. Research Objectives
    2. Limitations & Assumptions
    3. Market Scope & Segmentation
    4. Currency & Pricing Considered
  3. Market Opportunity Assessment
    1. Emerging Regions / Countries
    2. Emerging Companies
    3. Emerging Applications / End Use
  4. Market Trends
    1. Drivers
    2. Market Warning Factors
    3. Macro Economic Indicators
    4. Geopolitical Impact
    5. Technology Factors
  5. Market Assessment
    1. Porters Five Forces Analysis
    2. Value Chain Analysis
  6. Pulmonary Arterial Hypertension Market Size Analysis
    1. Introduction
    2. Pulmonary Arterial Hypertension Market Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
      1. Prostacyclin and Prostacyclin Analogs
      2. SGC Stimulators
      3. ERA
      4. PDE-5
  7. North America Pulmonary Arterial Hypertension Market Size Analysis
    1. Introduction
    2. Pulmonary Arterial Hypertension Market Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
      1. Prostacyclin and Prostacyclin Analogs
      2. SGC Stimulators
      3. ERA
      4. PDE-5
    3. U.S.
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Prostacyclin and Prostacyclin Analogs
        2. SGC Stimulators
        3. ERA
        4. PDE-5
    4. Canada
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Prostacyclin and Prostacyclin Analogs
        2. SGC Stimulators
        3. ERA
        4. PDE-5
  8. Europe Pulmonary Arterial Hypertension Market Size Analysis
    1. Introduction
    2. Pulmonary Arterial Hypertension Market Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
      1. Prostacyclin and Prostacyclin Analogs
      2. SGC Stimulators
      3. ERA
      4. PDE-5
    3. U.K.
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Prostacyclin and Prostacyclin Analogs
        2. SGC Stimulators
        3. ERA
        4. PDE-5
    4. Germany
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Prostacyclin and Prostacyclin Analogs
        2. SGC Stimulators
        3. ERA
        4. PDE-5
    5. France
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Prostacyclin and Prostacyclin Analogs
        2. SGC Stimulators
        3. ERA
        4. PDE-5
    6. Spain
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Prostacyclin and Prostacyclin Analogs
        2. SGC Stimulators
        3. ERA
        4. PDE-5
    7. Italy
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Prostacyclin and Prostacyclin Analogs
        2. SGC Stimulators
        3. ERA
        4. PDE-5
    8. Russia
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Prostacyclin and Prostacyclin Analogs
        2. SGC Stimulators
        3. ERA
        4. PDE-5
    9. Nordic
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Prostacyclin and Prostacyclin Analogs
        2. SGC Stimulators
        3. ERA
        4. PDE-5
    10. Benelux
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Prostacyclin and Prostacyclin Analogs
        2. SGC Stimulators
        3. ERA
        4. PDE-5
    11. Rest of Europe
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Prostacyclin and Prostacyclin Analogs
        2. SGC Stimulators
        3. ERA
        4. PDE-5
  9. APAC Pulmonary Arterial Hypertension Market Size Analysis
    1. Introduction
    2. Pulmonary Arterial Hypertension Market Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
      1. Prostacyclin and Prostacyclin Analogs
      2. SGC Stimulators
      3. ERA
      4. PDE-5
    3. China
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Prostacyclin and Prostacyclin Analogs
        2. SGC Stimulators
        3. ERA
        4. PDE-5
    4. Korea
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Prostacyclin and Prostacyclin Analogs
        2. SGC Stimulators
        3. ERA
        4. PDE-5
    5. Japan
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Prostacyclin and Prostacyclin Analogs
        2. SGC Stimulators
        3. ERA
        4. PDE-5
    6. India
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Prostacyclin and Prostacyclin Analogs
        2. SGC Stimulators
        3. ERA
        4. PDE-5
    7. Australia
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Prostacyclin and Prostacyclin Analogs
        2. SGC Stimulators
        3. ERA
        4. PDE-5
    8. Singapore
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Prostacyclin and Prostacyclin Analogs
        2. SGC Stimulators
        3. ERA
        4. PDE-5
    9. Taiwan
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Prostacyclin and Prostacyclin Analogs
        2. SGC Stimulators
        3. ERA
        4. PDE-5
    10. South East Asia
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Prostacyclin and Prostacyclin Analogs
        2. SGC Stimulators
        3. ERA
        4. PDE-5
    11. Rest of Asia-Pacific
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Prostacyclin and Prostacyclin Analogs
        2. SGC Stimulators
        3. ERA
        4. PDE-5
  10. Middle East and Africa Pulmonary Arterial Hypertension Market Size Analysis
    1. Introduction
    2. Pulmonary Arterial Hypertension Market Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
      1. Prostacyclin and Prostacyclin Analogs
      2. SGC Stimulators
      3. ERA
      4. PDE-5
    3. UAE
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Prostacyclin and Prostacyclin Analogs
        2. SGC Stimulators
        3. ERA
        4. PDE-5
    4. Turkey
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Prostacyclin and Prostacyclin Analogs
        2. SGC Stimulators
        3. ERA
        4. PDE-5
    5. Saudi Arabia
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Prostacyclin and Prostacyclin Analogs
        2. SGC Stimulators
        3. ERA
        4. PDE-5
    6. South Africa
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Prostacyclin and Prostacyclin Analogs
        2. SGC Stimulators
        3. ERA
        4. PDE-5
    7. Egypt
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Prostacyclin and Prostacyclin Analogs
        2. SGC Stimulators
        3. ERA
        4. PDE-5
    8. Nigeria
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Prostacyclin and Prostacyclin Analogs
        2. SGC Stimulators
        3. ERA
        4. PDE-5
    9. Rest of MEA
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Prostacyclin and Prostacyclin Analogs
        2. SGC Stimulators
        3. ERA
        4. PDE-5
  11. LATAM Pulmonary Arterial Hypertension Market Size Analysis
    1. Introduction
    2. Pulmonary Arterial Hypertension Market Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
      1. Prostacyclin and Prostacyclin Analogs
      2. SGC Stimulators
      3. ERA
      4. PDE-5
    3. Brazil
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Prostacyclin and Prostacyclin Analogs
        2. SGC Stimulators
        3. ERA
        4. PDE-5
    4. Mexico
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Prostacyclin and Prostacyclin Analogs
        2. SGC Stimulators
        3. ERA
        4. PDE-5
    5. Argentina
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Prostacyclin and Prostacyclin Analogs
        2. SGC Stimulators
        3. ERA
        4. PDE-5
    6. Chile
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Prostacyclin and Prostacyclin Analogs
        2. SGC Stimulators
        3. ERA
        4. PDE-5
    7. Colombia
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Prostacyclin and Prostacyclin Analogs
        2. SGC Stimulators
        3. ERA
        4. PDE-5
    8. Rest of LATAM
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Prostacyclin and Prostacyclin Analogs
        2. SGC Stimulators
        3. ERA
        4. PDE-5
  12. Competitive Landscape
    1. Pulmonary Arterial Hypertension Market Share By Players
    2. M&A Agreements & Collaboration Analysis
    3. Tier Structure Analysis
    4. Recent Developments
  13. Market Players Assessment
    1. Johnson and Johnson
      1. Overview
      2. Business Information
      3. Revenue
      4. ASP
      5. SWOT Analysis
      6. Recent Developments
    2. Gilead Sciences Inc.
    3. United Therapeutics Corporation
    4. Acceleron Pharma, Inc.
    5. GlaxoSmithKline plc (GSK)
    6. Pfizer Inc.
    7. Bayer AG.
  14. Research Methodology
    1. Research Data
      1. Secondary Data
        1. Major Secondary Sources
        2. Key Data from Secondary Sources
      2. Primary Data
        1. Key Data from Primary Sources
        2. Breakdown of Primaries
      3. Secondary And Primary Research
        1. Key Industry Insights
    2. Market Size Estimation
      1. Bottom-Up Approach
      2. Top-Down Approach
      3. Market Projection
    3. Research Assumptions
      1. Assumptions
    4. Limitations
    5. Risk Assessment
  15. Appendix
    1. Discussion Guide
    2. Customization Options
    3. Related Reports
  16. Disclaimer
Report Details
−
200+ Trusted Partners
LG Electronics AMCAD Engineering KOBE STEEL LTD. Hindustan National Glass & Industries Limited Voith Group International Paper Hansol Paper Whirlpool Corporation Sony Samsung Electronics Qualcomm Google Fiserv Veto-Pharma Nippon Becton Dickinson Merck Argon Medical Devices Abbott Ajinomoto Denon Doosan Meiji Seika Kaisha Ltd LG Chemicals LCY chemical group Bayer Airrane BASF Toyota Industries Nissan Motors Neenah Mitsubishi Hyundai Motor Company Honda CRP Industries Inc pewag LGE Panasonic Lubrizol Corporation Leonardo Johnson & Johnson HB Fuller MITSUBISHI CHEMICAL Hyundai Mobis Amazon
Download Free Sample
Reach out to us
+1 646 905 0080 (U.S.)
+44 203 695 0070 (U.K.)
sales@straitsresearch.com

We are featured on:

Straits Research
Address:
105, Panchshil The Golden Bell,
Koregaon Park Annexe, Mundhwa,
Pune, Maharashtra 411036
Contact Us:
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)

sales@straitsresearch.com

Quick Links
Help
Verified. Protected. Secure.
Duns
DMCA.com Protection Status
lets-encrypt
Secure Payments:
Secure Payments
Follow Us:
www.straitsresearch.com © Copyright . All rights Reserved.